Aldeyra Therapeutics, Inc.
ALDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $59 | $41 | $50 | $55 |
| Short-Term Investments | $16 | $41 | $40 | $47 |
| Receivables | $0 | $0 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $2 | $3 |
| Total Curr. Assets | $77 | $85 | $93 | $104 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $78 | $85 | $93 | $105 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $0 | $0 |
| Short-Term Debt | $15 | $15 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $6 | $6 | $6 | $6 |
| Other Curr. Liab. | $7 | $7 | $8 | $12 |
| Total Curr. Liab. | $28 | $30 | $14 | $19 |
| LT Debt | $0 | $0 | $15 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $15 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $29 | $30 | $30 | $34 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$477 | -$470 | -$460 | -$450 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $527 | $525 | $524 | $521 |
| Total Equity | $49 | $55 | $64 | $71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $78 | $85 | $93 | $105 |
| Net Debt | -$44 | -$26 | -$35 | -$39 |